Packaged bakery food company Flower Foods (NYSE: FLO) will be reporting results tomorrow before the bell. Here’s what you need to know.
Flowers Foods missed analysts’ revenue expectations by 0.7% last quarter, reporting revenues of $1.19 billion, flat year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ EBITDA estimates but a miss of analysts’ organic revenue estimates.
Is Flowers Foods a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Flowers Foods’s revenue to be flat year on year at $1.13 billion, slowing from the 4.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.21 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Flowers Foods has missed Wall Street’s revenue estimates six times over the last two years.
Looking at Flowers Foods’s peers in the consumer staples segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Tyson Foods delivered year-on-year revenue growth of 2.3%, beating analysts’ expectations by 1%, and Cal-Maine reported revenues up 82.5%, topping estimates by 27%. Tyson Foods’s stock price was unchanged after the results, and Cal-Maine’s price followed a similar reaction.
Read our full analysis of Tyson Foods’s results here and Cal-Maine’s results here.
Stocks, especially growth stocks where cash flows further in the future are more important to the story, have had a good 2024. An economic soft landing (so far), the start of the Fed's rate cutting campaign, and the election of Donald Trump were positives for the market, and while some of the consumer staples stocks have shown solid performance, the group has generally underpeformed, with share prices down 3.2% on average over the last month. Flowers Foods is down 1.5% during the same time and is heading into earnings with an average analyst price target of $23.50 (compared to the current share price of $19.64).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
